MBXMBX Biosciences, Inc.

HealthcareUSD
$66.87

The financials

MBX Biosciences, Inc. by the numbers

MBX Biosciences, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$41M−$22Mn/a
Net income−$37M−$19Mn/a
Diluted EPS−$0.78−$0.58n/a

Biotechnology

Ranks #16 of 145 by Smart Score

Compare peers
SLBT+12%
SL Science Holding Limited
PHVS+0.03%
Pharvaris N.V.
NRIX+16%
Nurix Therapeutics, Inc.
MLYS+2.2%
Mineralys Therapeutics, Inc.
BHVN+2.5%
Biohaven Ltd.
MRVI+6.2%
Maravai LifeSciences Holdings, Inc.